AzTrials
AzTrials

Blood Circulation DisorderNCT03700216

Construction of the Evaluation System of Limb Blood Circulation After Fracture of Limbs in Children

An observational study of Blood Circulation Disorder, run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is aimed to construct a multi-parameter early-warning model based on usage of mannitol, using multi-factor regression and combining with previous clinical experience, literature, expert opinions. Read more about this study

Who is it for?
Ages Up to 14 years
Conditions the study is for
Blood Circulation Disorder
How many people
201 participants
Where
1 siteChina
Study dates
1 Oct 2018to 30 Sep 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children with limb fractures diagnosed by X-ray film

Who may be able to join

  • Age from 0 to 14 years;
  • Children with limb fractures diagnosed by X-ray film;
  • The surgical method is open reduction and wire-pin fixation or steel plate internal fixation;
  • Children with postoperative plaster fixation;
  • Children whose guardian signed informed written consent.

Who cannot join

  • Children with nerve damage which have caused dysfunction such as sensory and motor;
  • Children with fracture in other parts or organic diseases.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200092

    Ting Zhu, PhD, +86-18101878907, zhuting@xinhuamed.com.cn

    Recruiting

Other trials in China

About this study

This study is aimed to construct a multi-parameter early-warning model based on usage of mannitol, using multi-factor regression and combining with previous clinical experience, literature, expert opinions. The investigators will evaluate the predictive value of the model for mannitol usage and gypsum cutting open through cohort study verification.

Read the detailed description

The investigator will retrospect the data of operative patients with limb fracture in Pediatric Orthopedics Unit of Shanghai Xinhua Hospital in 2016 to collect the basic information about this kind of patient, including age, gender, kind of fracture, temperature and color of skin, swell, artery pulse, laboratory test indicators, method of fixation, and the usage of mannitol. Then, combining the professionals' suggestions, the investigator will use multi-factor regression to identify the independent risk factors of blood circulation disorder. According to the independent risk factors, the early-warning model of blood circulation disorder will be built, and the rating scale as well. Finally, the critical value of blood circulation disorder after limb fracture will be set by receiver operating characteristic curve.

Keywords
limb Fracture, limb blood circulation, early-warning model, Children

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with Limb Blood circulation disorder

    Number of participants with circulatory disorders (using mannitol treatment) after limb fracture

    Measured: Within 1 year after mannitol treatment

Secondary outcomes (2)
  1. Number of adverse events

    The adverse events include acute ischemic necrosis, osteofascial compartment syndrome and disability.

    Measured: Within 1 year after mannitol treatment

  2. Blood oxygen saturation at the end of extremities

    Oxygen saturation is the fraction of oxygen-saturated hemoglobin relative to total hemoglobin (unsaturated + saturated) in the blood, which can reflect the status of blood circulation. Blood oxygen saturation can be get by using percutaneous oxygen saturation monitor.

    Measured: Within 1 year after mannitol treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2018
  2. Study start1 Oct 2018
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion30 Sep 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
201 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03700216
Sponsor's protocol ID
XH-18-014
Status last verified
Oct 2018
First submitted
26 Sep 2018
Last updated
19 Oct 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Blood Circulation Disorder, run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ting Zhu, PhD (+86-18101878907, zhuting@xinhuamed.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with Limb Blood circulation disorder (time frame: Within 1 year after mannitol treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in